Not applicableLooking for participantsNCT07068126What this trial is testingManagement of Children With Persistent ITP, A Novel ApproachWho this might be right forPersistent Immune Thrombocytopenia Assiut University 20
Testing effectiveness (Phase 2)Looking for participantsNCT07586813What this trial is testingRomiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid TumorsWho this might be right forPersistent Isolated Chemotherapy-Induced ThrombocytopeniaChemotherapy-Induced ThrombocytopeniaGastrointestinal Neoplasms+2 more Peking University People's Hospital 220
Not applicableStudy completedNCT03412188What this trial is testingThe Effect of Eltrombopag on the Expression of Platelet Collagen Receptor GPVI in Pediatric ITP.Who this might be right forIdiopathic Thrombocytopenic Purpura Nayera Hazaa Elsherif 36
Not applicableNot Yet RecruitingNCT07268898What this trial is testingNational Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) PatientsWho this might be right forImmune Thrombocytopenia (ITP) Institute of Hematology & Blood Diseases Hospital, China 500
Large-scale testing (Phase 3)Study completedNCT02868099What this trial is testingEfficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP)Who this might be right forImmune Thrombocytopenia Kyowa Kirin China Pharmaceutical Co., Ltd. 203
Testing effectiveness (Phase 2)Ended earlyNCT02566603What this trial is testingPRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITPWho this might be right forImmune Thrombocytopenia Protalex, Inc. 15
Testing effectiveness (Phase 2)Looking for participantsNCT07535645What this trial is testingBaricitinib for Post-HSCT Persistent ThrombocytopeniaWho this might be right forPersistent ThrombocytopeniaAllogeneic Hematopoietic Stem Cell Transplantation Peking University People's Hospital 28
Not applicableLooking for participantsNCT06817395What this trial is testingCognitive Dysfunction in Chronic and Persistent Immune ThrombocytopeniaWho this might be right forImmune Thrombocytopenia Massachusetts General Hospital 100
Post-approval studies (Phase 4)Study completedNCT03119974What this trial is testingRate of Prolonged Response After Stopping Thrombopoietin-receptor Agonists Treatment in ITPWho this might be right forPersistent or Chronic ITP Assistance Publique - Hôpitaux de Paris 48
Large-scale testing (Phase 3)Study completedNCT02077192What this trial is testingOpen Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)Who this might be right forImmune Thrombocytopenic Purpura Rigel Pharmaceuticals 123
Large-scale testing (Phase 3)UnknownNCT03177629What this trial is testingH. Pylori Eradication for Moderate ITPWho this might be right forImmune Thrombocytopenic PurpuraHelicobacter PyloriImmune Thrombocytopenia Seoul National University Hospital 54
Not applicableStudy completedNCT03154385What this trial is testingEfficacy and Safety Assessment of a Treatment Combining Rituximab and Belimumab in Adults With Persistent Immune ThrombocytopeniaWho this might be right forImmune Thrombocytopenia Assistance Publique - Hôpitaux de Paris 15
Large-scale testing (Phase 3)Study completedNCT02076399What this trial is testingA Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)Who this might be right forImmune Thrombocytopenic Purpura Rigel Pharmaceuticals 76
Large-scale testing (Phase 3)Looking for participantsNCT05338190What this trial is testingEfficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune ThrombocytopeniaWho this might be right forPrimary Immune Thrombocytopenia (ITP) Assistance Publique - Hôpitaux de Paris 132
Large-scale testing (Phase 3)WithdrawnNCT02649504What this trial is testingRituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune ThrombocytopeniaWho this might be right forImmune Thrombocytopenia Weill Medical College of Cornell University
Testing effectiveness (Phase 2)Ended earlyNCT01153919What this trial is testingRomiplostim in Treating Hepatitis C-Infected Patients With ThrombocytopeniaWho this might be right forHepatitis C InfectionThrombocytopenia University of Southern California 27
Large-scale testing (Phase 3)Ended earlyNCT04224688What this trial is testingAssess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)Who this might be right forPrimary Immune Thrombocytopenia UCB Biopharma SRL 30
Large-scale testing (Phase 3)Ended earlyNCT04200456What this trial is testingEvaluate the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)Who this might be right forPrimary Immune Thrombocytopenia UCB Biopharma SRL 33
Testing effectiveness (Phase 2)Study completedNCT04669600What this trial is testingA Phase 2a Study Evaluating BIVV020 in Adults With Persistent/Chronic Immune Thrombocytopenia (ITP)Who this might be right forImmune Thrombocytopenia (ITP) Bioverativ, a Sanofi company 12
Testing effectiveness (Phase 2)Study completedNCT05772546What this trial is testingAvatrombopag vs. Placebo for CIT in GI MalignanciesWho this might be right forGastrointestinal CancerGastrointestinal NeoplasmsChemotherapy-Induced Thrombocytopenia Hanny Al-Samkari, MD 49